Tebas P - Search Results

1

Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed.

Ristig MB, Crippin J, Aberg JA, Powderly WG, Lisker-Melman M, Kessels L, Tebas P. Ristig MB, et al. Among authors: tebas p. J Infect Dis. 2002 Dec 15;186(12):1844-7. doi: 10.1086/345770. Epub 2002 Nov 22. J Infect Dis. 2002. PMID: 12447773 Clinical Trial.

2

A rapid assay to screen for drug-resistant herpes simplex virus.

Tebas P, Scholl D, Jollick J, McHarg K, Arens M, Olivo PD. Tebas P, et al. J Infect Dis. 1998 Jan;177(1):217-20. doi: 10.1086/517357. J Infect Dis. 1998. PMID: 9419192

3

Virologic responses to a ritonavir--saquinavir-containing regimen in patients who had previously failed nelfinavir.

Tebas P, Patick AK, Kane EM, Klebert MK, Simpson JH, Erice A, Powderly WG, Henry K. Tebas P, et al. AIDS. 1999 Feb 4;13(2):F23-8. doi: 10.1097/00002030-199902040-00002. AIDS. 1999. PMID: 10202820 Clinical Trial.

4

Insulin resistance in HIV protease inhibitor-associated diabetes.

Yarasheski KE, Tebas P, Sigmund C, Dagogo-Jack S, Bohrer A, Turk J, Halban PA, Cryer PE, Powderly WG. Yarasheski KE, et al. Among authors: tebas p. J Acquir Immune Defic Syndr. 1999 Jul 1;21(3):209-16. doi: 10.1097/00126334-199907010-00005. J Acquir Immune Defic Syndr. 1999. PMID: 10421244 Free PMC article.

5

Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy.

Tantisiriwat W, Tebas P, Clifford DB, Powderly WG, Fichtenbaum CJ. Tantisiriwat W, et al. Among authors: tebas p. Clin Infect Dis. 1999 May;28(5):1152-4. doi: 10.1086/514762. Clin Infect Dis. 1999. PMID: 10452651

6

Nelfinavir, a new protease inhibitor: early clinical results.

Powderly WG, Tebas P. Powderly WG, et al. Among authors: tebas p. AIDS. 1999 Sep;13 Suppl 1:S41-8. AIDS. 1999. PMID: 10546784 Review.

7

Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy.

Tebas P, Powderly WG, Claxton S, Marin D, Tantisiriwat W, Teitelbaum SL, Yarasheski KE. Tebas P, et al. AIDS. 2000 Mar 10;14(4):F63-7. doi: 10.1097/00002030-200003100-00005. AIDS. 2000. PMID: 10770534 Free PMC article.

8

Response to 'Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy' by Drs Weil and Lenhard.

Tebas P, Powderly W, Yarasheski K. Tebas P, et al. AIDS. 2000 Oct 20;14(15):2417. doi: 10.1097/00002030-200010200-00031. AIDS. 2000. PMID: 11089638 No abstract available.

9

Resistance exercise training reduces hypertriglyceridemia in HIV-infected men treated with antiviral therapy.

Yarasheski KE, Tebas P, Stanerson B, Claxton S, Marin D, Bae K, Kennedy M, Tantisiriwat W, Powderly WG. Yarasheski KE, et al. Among authors: tebas p. J Appl Physiol (1985). 2001 Jan;90(1):133-8. doi: 10.1152/jappl.2001.90.1.133. J Appl Physiol (1985). 2001. PMID: 11133903 Free article.

10

Elevated lactate levels in hospitalized persons with HIV infection.

Tantisiriwat W, Tebas P, Polish LB, Casabar E, Powderly WG, Fichtenbaum CJ. Tantisiriwat W, et al. Among authors: tebas p. AIDS Res Hum Retroviruses. 2001 Feb 10;17(3):195-201. doi: 10.1089/088922201750063106. AIDS Res Hum Retroviruses. 2001. PMID: 11177401

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

284 results

Search Page